Soliano, Baby Girl .
HRN: 26-68-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2025
AMPICILLIN 250MG (VIAL)
02/14/2025
02/21/2025
IV
125mg
Q12hours
PSNB Sec To NID
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes